Literature DB >> 15070676

Involvement of casein kinase Iepsilon in cytokine-induced granulocytic differentiation.

Atsuo Okamura1, Nobuko Iwata, Aki Nagata, Akira Tamekane, Manabu Shimoyama, Hiroshi Gomyo, Kimikazu Yakushijin, Norinaga Urahama, Miyuki Hamaguchi, Chie Fukui, Kazuo Chihara, Mitsuhiro Ito, Toshimitsu Matsui.   

Abstract

Two closely related casein kinase I (CKI) isoforms, CKIdelta and CKIepsilon, are ubiquitously expressed in many human tissues, but their specific biologic function remains to be clarified. Here, we provide the first evidence that CKIepsilon is involved in hematopoietic cell differentiation. CKIepsilon, but not CKIdelta, was down-regulated along with human granulocytic differentiation. The specific down-regulation was observed in granulocyte colony-stimulating factor (G-CSF)-induced cell differentiation of murine interleukin-3 (IL-3)-dependent myeloid progenitor 32D cells. Introduction of wild-type (WT)-CKIepsilon into 32D cells inhibited the G-CSF-induced cell differentiation, whereas kinase-negative (KN)-CKIepsilon promoted the differentiation. Neither WT- nor KN-CKIepsilon affected IL-3-dependent cell growth. Moreover, introduction of WT- or KN-CKIdelta did not affect the cytokine-induced cell growth and differentiation. While G-CSF-induced activation of signal transducers and activators of transcription 3 (STAT3) was sustained by KN-CKIepsilon, STAT3 activation was attenuated by WT-CKIepsilon. This may be explained by the fact that the suppressor of cytokine signaling 3 (SOCS3) was stabilized by its physical association with CKIepsilon. Such stabilization by CKIepsilon was also seen in IL-3-induced beta-catenin. The stabilization of downstream components of cytokine and Wnt signaling by CKIepsilon might be critical for integration of several intracellular signaling pathways to a cell-specific biologic response in hematopoietic cell self-renewal.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070676     DOI: 10.1182/blood-2003-08-2768

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia.

Authors:  Sigal Gery; Adrian F Gombart; William S Yi; Chloe Koeffler; Wolf-K Hofmann; H Phillip Koeffler
Journal:  Blood       Date:  2005-06-28       Impact factor: 22.113

2.  Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Ag-transgenic mice.

Authors:  Anja C Utz; Heidrun Hirner; Annette Blatz; Andreas Hillenbrand; Bernhard Schmidt; Wolfgang Deppert; Doris Henne-Bruns; Dietmar Fischer; Dietmar R Thal; Frank Leithäuser; Uwe Knippschild
Journal:  J Histochem Cytochem       Date:  2009-09-15       Impact factor: 2.479

Review 3.  The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.

Authors:  Uwe Knippschild; Marc Krüger; Julia Richter; Pengfei Xu; Balbina García-Reyes; Christian Peifer; Jakob Halekotte; Vasiliy Bakulev; Joachim Bischof
Journal:  Front Oncol       Date:  2014-05-19       Impact factor: 6.244

4.  Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.

Authors:  Jinsong Qiu; Bing Zhou; Felicitas Thol; Yu Zhou; Liang Chen; Changwei Shao; Christopher DeBoever; Jiayi Hou; Hairi Li; Anuhar Chaturvedi; Arnold Ganser; Rafael Bejar; Dong-Er Zhang; Xiang-Dong Fu; Michael Heuser
Journal:  RNA       Date:  2016-08-04       Impact factor: 4.942

5.  Co-expression of long non-coding RNAs and autism risk genes in the developing human brain.

Authors:  Steven B Cogill; Anand K Srivastava; Mary Qu Yang; Liangjiang Wang
Journal:  BMC Syst Biol       Date:  2018-12-14

6.  Immunohistochemical characterisation of cell-type specific expression of CK1delta in various tissues of young adult BALB/c mice.

Authors:  Jürgen Löhler; Heidrun Hirner; Bernhard Schmidt; Klaus Kramer; Dietmar Fischer; Dietmar R Thal; Frank Leithäuser; Uwe Knippschild
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.